Strategic Blueprint LLC Sells 26 Shares of Axon Enterprise, Inc $AXON

Strategic Blueprint LLC reduced its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 2.8% during the second quarter, Holdings Channel reports. The fund owned 915 shares of the biotechnology company’s stock after selling 26 shares during the period. Strategic Blueprint LLC’s holdings in Axon Enterprise were worth $758,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Vanguard Group Inc. grew its position in Axon Enterprise by 2.2% during the first quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company’s stock valued at $4,540,005,000 after acquiring an additional 185,571 shares during the last quarter. Alliancebernstein L.P. grew its holdings in shares of Axon Enterprise by 15.9% in the first quarter. Alliancebernstein L.P. now owns 1,284,935 shares of the biotechnology company’s stock worth $675,812,000 after purchasing an additional 175,890 shares during the last quarter. Westfield Capital Management Co. LP grew its holdings in shares of Axon Enterprise by 29.8% in the first quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company’s stock worth $487,977,000 after purchasing an additional 212,931 shares during the last quarter. Northern Trust Corp grew its holdings in shares of Axon Enterprise by 1.2% in the first quarter. Northern Trust Corp now owns 725,720 shares of the biotechnology company’s stock worth $381,692,000 after purchasing an additional 8,794 shares during the last quarter. Finally, Jennison Associates LLC grew its holdings in shares of Axon Enterprise by 23,203.7% in the first quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company’s stock worth $322,961,000 after purchasing an additional 611,418 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. Northland Securities set a $800.00 target price on shares of Axon Enterprise in a report on Tuesday, August 5th. Craig Hallum upgraded shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 target price on the stock in a report on Tuesday, August 5th. JPMorgan Chase & Co. raised their target price on shares of Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a report on Thursday, July 17th. Morgan Stanley set a $885.00 target price on shares of Axon Enterprise and gave the stock an “overweight” rating in a report on Friday, July 11th. Finally, Raymond James Financial restated an “outperform” rating and issued a $855.00 target price (up previously from $645.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Fourteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus target price of $841.64.

Insider Transactions at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 7,891 shares of the stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the sale, the insider directly owned 144,538 shares of the company’s stock, valued at approximately $108,417,953.80. This represents a 5.18% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Hadi Partovi acquired 1,358 shares of Axon Enterprise stock in a transaction on Wednesday, August 13th. The shares were purchased at an average price of $740.00 per share, with a total value of $1,004,920.00. Following the completion of the purchase, the director owned 237,938 shares in the company, valued at $176,074,120. This represents a 0.57% increase in their position. The disclosure for this purchase can be found here. Insiders have sold 59,932 shares of company stock worth $45,115,616 over the last quarter. Corporate insiders own 4.40% of the company’s stock.

Axon Enterprise Stock Up 2.7%

AXON stock opened at $735.95 on Friday. The business’s 50 day moving average price is $733.17 and its two-hundred day moving average price is $725.28. Axon Enterprise, Inc has a fifty-two week low of $422.38 and a fifty-two week high of $885.91. The company has a market capitalization of $57.77 billion, a price-to-earnings ratio of 181.72, a price-to-earnings-growth ratio of 28.58 and a beta of 1.41. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.58. The company had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm’s quarterly revenue was up 32.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.